Skip to content
HowShorted

Arcutis Biotherapeutics, Inc. short interest in 2026

In 2026, Arcutis Biotherapeutics, Inc.'s disclosed short interest ran from 12.43% of shares outstanding on 15 Jan 2026 to 14.69% on 15 Sep 2026, a change of +2.26 percentage points. The year's high was 14.69% on 15 Sep 2026 and its low 10.09% on 31 Jul 2026, averaging 12.72% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.62 days on 30 Apr 2026. Full history: Arcutis Biotherapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Arcutis Biotherapeutics, Inc. in 2026

2026 in figures

Start of year
12.43% (15 Jan 2026)
End of year
14.69% (15 Sep 2026)
Change
+2.26 pp
High
14.69% (15 Sep 2026)
Low
10.09% (31 Jul 2026)
Average
12.72%
Highest days to cover
16.62 (30 Apr 2026)
SEC filings marked
5

Every report in 2026

Arcutis Biotherapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202612.43%8.41
30 Jan 202613.07%13.88
13 Feb 202613.37%14.06
27 Feb 202612.48%9.7310-K filed, results (8-K)
13 Mar 202612.86%12.56
31 Mar 202613.72%11.11
15 Apr 202613.54%15.62
30 Apr 202613.49%16.62
15 May 202614.03%7.3010-Q filed
29 May 202612.97%8.44
15 Jun 202612.65%10.04
30 Jun 202611.21%6.33
15 Jul 202610.84%9.34
31 Jul 202610.09%10.74
14 Aug 202611.71%8.0410-Q filed, results (8-K)
31 Aug 202613.17%9.41
15 Sep 202614.69%8.54

See also: Arcutis Biotherapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.